Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06692881 | RECRUITING | Migraine

Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada
Sponsor:

AbbVie

Brief Summary:

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will evaluate function and satisfaction with oral ubrogepant in treating adult participants after multiple migraine attacks. Ubrogepant is a drug approved for the acute treatment of migraine in adults. Approximately 167 participants will be enrolled in approximately 10-15 sites across Canada. Participants will receive ubrogepant as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 12 weeks. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

Condition or disease

Migraine

Study Type : OBSERVATIONAL
Estimated Enrollment : 167 participants
Official Title : Evaluation of Function And Satisfaction of UbrogepanT-treated Migraine Patients in Canada (FAST): Prospective, Observational, Real-world Study
Actual Study Start Date : 2025-02-12
Estimated Primary Completion Date : 2026-01
Estimated Study Completion Date : 2026-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Participants able to give voluntary informed consent before starting any study-related assessments or procedures (to be obtained/documented as per local regulations).
  • * Adults (≥18 years of age) at time of informed consent.
  • * Participants with at least 1-year history of migraine with or without aura consistent with a diagnosis according to the ICHD-3 (2018).
  • * Participants with history of experiencing at least 3 migraine attacks per month with moderate to severe symptoms
  • * Participants prescribed ubrogepant by investigator for the acute treatment of migraine according to local product label, independent of and prior to study participation
  • * Participants willing and able to comply with the requirements of the study.
  • * Participants with access to an electronic device (mobile phone, tablet, laptop, etc.) with internet access.
Exclusion Criteria
  • * Participants previously exposed to a ubrogepant or rimegepant as routine therapy or through a clinical trial.
  • * Participants with history of known contraindications to ubrogepant as per local labeling.
  • * Participants Pregnant or planning to be pregnant or of childbearing potential not using contraception
  • * Participants enrolled in any interventional studies that may include investigational compounds for migraine or non-AbbVie observational studies.
  • * History or current evidence of any condition that might interfere with their ability to comply with the study requirements, in the opinion of the investigator.
Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

Location Details

NCT06692881

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

Canada, Alberta

Calgary Headache Assessment and Management Program /ID# 271475

Calgary, Alberta, Canada, T3M 1M4

RECRUITING

Canada, British Columbia

Dr May Ong INC /ID# 271474

Vancouver, British Columbia, Canada, V6Z 2E8

RECRUITING

Canada, New Scotia

Maritime Neurology /ID# 271867

Halifax, Nova Scotia, Canada, B3R 1V9

RECRUITING

Canada, Ontario

Neurocentre of Eastern Ontario /ID# 271865

Kingston, Ontario, Canada, As a throat

RECRUITING

Canada, Ontario

Centricity /ID# 271477

London, Ontario, Canada, N6a 2c2

RECRUITING

Canada, Ontario

London Health Sciences Centre - Victoria Hospital & Children's Hospital /ID# 272031

London, Ontario, Canada, Wicker

RECRUITING

Canada, Ontario

360 Concussion Care /ID# 271972

Ottawa, Ontario, Canada, K1H 7X7

RECRUITING

Canada, Quebec

St-Louis /ID research center# 272843

Levi's, Quebec, Canada, G6W 0M5

RECRUITING

Canada, Quebec

Genge Partners /ID# 273302

Montreal, Quebec, Canada, H4A 3T2

RECRUITING

Canada, Quebec

Diex Research Sherbrooke /ID# 271677

Sherbrooke, Quebec, Canada, J1l 0h8